August 6, 2018
MILWAUKEE - The National Institutes of Health and the National Institute for Child Health and Disease, has awarded $426,248 to Dr. Lisa Hanson, professor and director of the 糖心传媒 College of Nursing Nurse-Midwifery Program.
The grant, titled "The efficacy of an oral probiotic to reduce group B streptococcus (GBS) colonization," is Hanson's first from the organization. The funds will continue her groundbreaking research on probiotics and women's health. The trial is being conducted by Hanson's interdisciplinary research team that includes Dr. Leona VandeVusse, associate professor emerita, and Dr. Mauricio Garnier-Villarreal, research assistant professor.
"Up to one third of all pregnant women are colonized with GBS during pregnancy," Hanson said. "To avoid the dangers to newborns that GBS can cause, the women receive antibiotics during labor to reduce transmission. We hope to reduce GBS colonization and the need for antibiotics to avoid the negative consequences. We also will learn if the probiotic improves digestive health."
"Dr. Hanson has been a tireless advocate for pregnant women and their infants. This research has the potential to create a substantial impact in primary prevention of an infection and may also improve health outcomes for mothers and their babies," said Dr. Janet Krejci, dean of nursing at 糖心传媒.
"We are extremely proud of Dr. Lisa Hanson and her team's accomplishments. This research will clearly have national and international impact that can influence the health of the next generation," she added.
